Loading...
Header Logo
Keywords
Last Name
Institution

Alan Schneyer M.S., Ph.D.

TitleResearch Professor
InstitutionUniversity of Massachusetts Amherst
DepartmentCollege of Natural Sciences
Address431 Integrated Science Center
Amherst, MA 01003
Phone617-922-5384
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Brown ML, Schneyer A. A Decade Later: Revisiting the TGFß Family's Role in Diabetes. Trends Endocrinol Metab. 2020 Nov 28. PMID: 33261990.
      View in: PubMed
    2. Li Y, Fortin J, Ongaro L, Zhou X, Boehm U, Schneyer A, Bernard DJ, Lin HY. Betaglycan (TGFBR3) functions as an inhibin A, but not inhibin B, co-receptor in pituitary gonadotrope cells in mice. Endocrinology. 2018 Oct 25. PMID: 30364975.
      View in: PubMed
    3. Meng C, Liu W, Huang H, Wang Y, Chen B, Freeman GJ, Schneyer A, Lin HY, Xia Y. Repulsive Guidance Molecule b (RGMb) Is Dispensable for Normal Gonadal Function in Mice. Biol Reprod. 2016 Apr; 94(4):78. PMID: 26911425.
      View in: PubMed
    4. Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice. Endocrinology. 2016 Mar; 157(3):1146-62. PMID: 26735394.
      View in: PubMed
    5. Brown ML, Andrzejewski D, Burnside A, Schneyer AL. Activin Enhances a- to ß-Cell Transdifferentiation as a Source For ß-Cells In Male FSTL3 Knockout Mice. Endocrinology. 2016 Mar; 157(3):1043-54. PMID: 26727106.
      View in: PubMed
    6. Andrzejewski D, Brown ML, Ungerleider N, Burnside A, Schneyer AL. Activins A and B Regulate Fate-Determining Gene Expression in Islet Cell Lines and Islet Cells From Male Mice. Endocrinology. 2015 Jul; 156(7):2440-50. PMID: 25961841.
      View in: PubMed
    7. Meng C, Guo N, Wei Q, Shi F, Schneyer AL, Xia Y, Mao D. Expression of repulsive guidance molecule b (RGMb) in the uterus and ovary during the estrous cycle in rats. Acta Histochem. 2014 Oct; 116(8):1231-6. PMID: 25085051.
      View in: PubMed
    8. Brown ML, Ungerleider N, Bonomi L, Andrzejewski D, Burnside A, Schneyer A. Effects of activin A on survival, function and gene expression of pancreatic islets from non-diabetic and diabetic human donors. Islets. 2014; 6(5-6):e1017226. PMID: 25833251.
      View in: PubMed
    9. Ungerleider NA, Bonomi LM, Brown ML, Schneyer AL. Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice. Endocrinology. 2013 Jun; 154(6):2025-33. PMID: 23533219.
      View in: PubMed
    10. Oldknow KJ, Seebacher J, Goswami T, Villen J, Pitsillides AA, O'Shaughnessy PJ, Gygi SP, Schneyer AL, Mukherjee A. Follistatin-like 3 (FSTL3) mediated silencing of transforming growth factor ß (TGFß) signaling is essential for testicular aging and regulating testis size. Endocrinology. 2013 Mar; 154(3):1310-20. PMID: 23407452.
      View in: PubMed
    11. Bonomi L, Brown M, Ungerleider N, Muse M, Matzuk MM, Schneyer A. Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity. Am J Physiol Endocrinol Metab. 2012 Sep 1; 303(5):E587-96. PMID: 22739106.
      View in: PubMed
    12. Brown ML, Kimura F, Bonomi LM, Ungerleider NA, Schneyer AL. Differential synthesis and action of TGFß superfamily ligands in mouse and rat islets. Islets. 2011 Nov-Dec; 3(6):367-75. PMID: 21964310.
      View in: PubMed
    13. Schneyer A. Getting big on BPA: role for BPA in obesity? Endocrinology. 2011 Sep; 152(9):3301-3. PMID: 21862570.
      View in: PubMed
    14. Brown ML, Bonomi L, Ungerleider N, Zina J, Kimura F, Mukherjee A, Sidis Y, Schneyer A. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obesity (Silver Spring). 2011 Oct; 19(10):1940-9. PMID: 21546932.
      View in: PubMed
    15. Dunphy KA, Schneyer AL, Hagen MJ, Jerry DJ. The role of activin in mammary gland development and oncogenesis. J Mammary Gland Biol Neoplasia. 2011 Jun; 16(2):117-26. PMID: 21475961.
      View in: PubMed
    16. Kimura F, Bonomi LM, Schneyer AL. Follistatin regulates germ cell nest breakdown and primordial follicle formation. Endocrinology. 2011 Feb; 152(2):697-706. PMID: 21106872.
      View in: PubMed
    17. Dasarathy S, McCullough AJ, Muc S, Schneyer A, Bennett CD, Dodig M, Kalhan SC. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J Hepatol. 2011 May; 54(5):915-21. PMID: 21145817.
      View in: PubMed
    18. Brown ML, Schneyer AL. Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis. Trends Endocrinol Metab. 2010 Jul; 21(7):441-8. PMID: 20382030.
      View in: PubMed
    19. Xia Y, Babitt JL, Bouley R, Zhang Y, Da Silva N, Chen S, Zhuang Z, Samad TA, Brenner GJ, Anderson JL, Hong CC, Schneyer AL, Brown D, Lin HY. Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells. J Am Soc Nephrol. 2010 Apr; 21(4):666-77. PMID: 20167703.
      View in: PubMed
    20. vom Saal FS, Akingbemi BT, Belcher SM, Crain DA, Crews D, Guidice LC, Hunt PA, Leranth C, Myers JP, Nadal A, Olea N, Padmanabhan V, Rosenfeld CS, Schneyer A, Schoenfelder G, Sonnenschein C, Soto AM, Stahlhut RW, Swan SH, Vandenberg LN, Wang HS, Watson CS, Welshons WV, Zoeller RT. Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci. 2010 Jun; 115(2):612-3; author reply 614-20. PMID: 20164146.
      View in: PubMed
    21. Kimura F, Sidis Y, Bonomi L, Xia Y, Schneyer A. The follistatin-288 isoform alone is sufficient for survival but not for normal fertility in mice. Endocrinology. 2010 Mar; 151(3):1310-9. PMID: 20032047.
      View in: PubMed
    22. Thadhani R, Powe CE, Tjoa ML, Khankin E, Ye J, Ecker J, Schneyer A, Karumanchi SA. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care. 2010 Mar; 33(3):664-9. PMID: 20007937.
      View in: PubMed
    23. Xia Y, Schneyer AL. The biology of activin: recent advances in structure, regulation and function. J Endocrinol. 2009 Jul; 202(1):1-12. PMID: 19273500.
      View in: PubMed
    24. Stamler R, Keutmann HT, Sidis Y, Kattamuri C, Schneyer A, Thompson TB. The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity. J Biol Chem. 2008 Nov 21; 283(47):32831-8. PMID: 18768470.
      View in: PubMed
    25. Schneyer AL, Sidis Y, Gulati A, Sun JL, Keutmann H, Krasney PA. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology. 2008 Sep; 149(9):4589-95. PMID: 18535106.
      View in: PubMed
    26. Lambert-Messerlian G, Eklund E, Pinar H, Tantravahi U, Schneyer AL. Activin subunit and receptor expression in normal and cleft human fetal palate tissues. Pediatr Dev Pathol. 2007 Nov-Dec; 10(6):436-45. PMID: 18001154.
      View in: PubMed
    27. Xia Y, Yu PB, Sidis Y, Beppu H, Bloch KD, Schneyer AL, Lin HY. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. J Biol Chem. 2007 Jun 22; 282(25):18129-40. PMID: 17472960.
      View in: PubMed
    28. Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1348-53. PMID: 17229845.
      View in: PubMed
    29. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology. 2006 Jul; 147(7):3586-97. PMID: 16627583.
      View in: PubMed
    30. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006 May; 38(5):531-9. PMID: 16604073.
      View in: PubMed
    31. Saito S, Sidis Y, Mukherjee A, Xia Y, Schneyer A. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. Endocrinology. 2005 Dec; 146(12):5052-62. PMID: 16150905.
      View in: PubMed
    32. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM, Schneyer AL. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab. 2005 Oct; 90(10):5582-7. PMID: 16030174.
      View in: PubMed
    33. Babitt JL, Zhang Y, Samad TA, Xia Y, Tang J, Campagna JA, Schneyer AL, Woolf CJ, Lin HY. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem. 2005 Aug 19; 280(33):29820-7. PMID: 15975920.
      View in: PubMed
    34. Xia Y, Sidis Y, Mukherjee A, Samad TA, Brenner G, Woolf CJ, Lin HY, Schneyer A. Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis. Endocrinology. 2005 Aug; 146(8):3614-21. PMID: 15890774.
      View in: PubMed
    35. Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL, Lin HY, Brivanlou AH, Attisano L, Woolf CJ. DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem. 2005 Apr 8; 280(14):14122-9. PMID: 15671031.
      View in: PubMed
    36. Schneyer A, Sidis Y, Xia Y, Saito S, del Re E, Lin HY, Keutmann H. Differential actions of follistatin and follistatin-like 3. Mol Cell Endocrinol. 2004 Oct 15; 225(1-2):25-8. PMID: 15451564.
      View in: PubMed
    37. del Re E, Sidis Y, Fabrizio DA, Lin HY, Schneyer A. Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system. J Biol Chem. 2004 Dec 17; 279(51):53126-35. PMID: 15475360.
      View in: PubMed
    38. Sidis Y, Schneyer AL, Keutmann HT. Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology. 2005 Jan; 146(1):130-6. PMID: 15471966.
      View in: PubMed
    39. Schneyer AL, Wang Q, Sidis Y, Sluss PM. Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab. 2004 Oct; 89(10):5067-75. PMID: 15472207.
      View in: PubMed
    40. Schneyer A. Inhibins: a historical perspective. Semin Reprod Med. 2004 Aug; 22(3):161-4. PMID: 15319818.
      View in: PubMed
    41. del Re E, Babitt JL, Pirani A, Schneyer AL, Lin HY. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. J Biol Chem. 2004 May 21; 279(21):22765-72. PMID: 14996829.
      View in: PubMed
    42. Xia Y, Sidis Y, Schneyer A. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice. Mol Endocrinol. 2004 Apr; 18(4):979-94. PMID: 14739256.
      View in: PubMed
    43. Welt CK, Schneyer AL, Heist K, Mantzoros CS. Leptin and soluble leptin receptor in follicular fluid. J Assist Reprod Genet. 2003 Dec; 20(12):495-501. PMID: 15035548.
      View in: PubMed
    44. Keutmann HT, Schneyer AL, Sidis Y. The role of follistatin domains in follistatin biological action. Mol Endocrinol. 2004 Jan; 18(1):228-40. PMID: 14563935.
      View in: PubMed
    45. Schneyer A, Schoen A, Quigg A, Sidis Y. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology. 2003 May; 144(5):1671-4. PMID: 12697670.
      View in: PubMed
    46. Seifer DB, Lambert-Messerlian G, Schneyer AL. Ovarian brain-derived neurotrophic factor is present in follicular fluid from normally cycling women. Fertil Steril. 2003 Feb; 79(2):451-2. PMID: 12568867.
      View in: PubMed
    47. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood). 2002 Oct; 227(9):724-52. PMID: 12324653.
      View in: PubMed
    48. Di Simone N, Schneyer AL, Caliandro D, Castellani R, Caruso A. Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol. Mol Cell Endocrinol. 2002 Jun 28; 192(1-2):187-95. PMID: 12088879.
      View in: PubMed
    49. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology. 2002 May; 143(5):1613-24. PMID: 11956142.
      View in: PubMed
    For assistance with using Profiles, please contact Profiles Support
    Schneyer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _